Practical Considerations for Clinicians When adding GLP1s to a liver-focused treatment plan: Evaluate contraindications (e.g., history of medullary thyroid cancer) Educate patients about common side effects and gradual dose titration Use liver biomarkers and imaging to monitor response over time Ensure cost and access considerations are addressed up front For additional guidance, consult Healthcare.pro or professional society recommendations to stay current on metabolic liver disease management
Everyone in the GLP-1 community is welcome creators and non-creators alike, whether you're just starting, well along the way, or in maintenance
the ubiquitin E1 inhibitor MLN7243 exhibits selective toxicity toward cutaneous squamous cell carcinoma cells while sparing normal keratinocytes, highlighting opportunities for tissue-specific UPS modulation
O motivo que mais chama ateno da gerncia o de uso no prescrito em bula, conhecido como off-label, ou de uso em indicao no aprovada
Le stress oxydatif survient lorsque lquilibre entre les ERO et les antioxydants est perturb
After 10 months on Wegovy, this user successfully lost 80 pounds (36.3 kg), going from 250 lbs (113.4 kg) to 170 lbs (77.1 kg)